Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Gremmel

Showing results (61-70 of 133) with videos related to

Pageof 14
Sort By:
Angiology|February 28, 2018
Low Levels of High-Density Lipoprotein Cholesterol Are Linked to Impaired Clopidogrel-Mediated Platelet InhibitionPatricia P Wadowski, Silvia Lee, Christoph W Kopp, et al.
International Journal of Cardiology|October 9, 2012
Residual platelet activation through protease-activated receptors (PAR)-1 and -4 in patients on P2Y12 inhibitorsRoza Badr Eslam, Irene M Lang, Renate Koppensteiner, et al.
Journal of Clinical Medicine|June 7, 2020
Platelet-to-lymphocyte and Neutrophil-to-lymphocyte Ratios Predict Target Vessel Restenosis after Infrainguinal Angioplasty with Stent ImplantationSilvia Lee, Timothy Hoberstorfer, Patricia P Wadowski, et al.
Frontiers in Immunology|March 11, 2021
Glycocalyx as Possible Limiting Factor in COVID-19Patricia P Wadowski, Bernd Jilma, Christoph W Kopp, et al.
Thrombosis Research|March 29, 2017
Plasminogen activator inhibitor-1 4G/5G genotype and residual venous occlusion following acute unprovoked deep vein thrombosis of the lower limb: A prospective cohort studyGeorgiana-Aura Giurgea, Sophie Brunner-Ziegler, Bernd Jilma, et al.
European Journal of Clinical Investigation|October 14, 2016
β-blockers are associated with decreased leucocyte-platelet aggregate formation and lower residual platelet reactivity to adenosine diphosphate after angioplasty and stentingSilvia Lee, Markus Durstberger, Beate Eichelberger, et al.
Seminars in Thrombosis and Hemostasis|June 18, 2024
Platelet Pathophysiology: Unexpected New Research DirectionsAlan D Michelson, Andrew L Frelinger Iii, Robin L Haynes, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 5, 2013
Chronic kidney disease is associated with increased platelet activation and poor response to antiplatelet therapyThomas Gremmel, Markus Müller, Sabine Steiner, et al.
Cardiovascular Drugs and Therapy|December 18, 2020
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity?Maximilian Tscharre, Patricia P Wadowski, Constantin Weikert, et al.
Journal of Atherosclerosis and Thrombosis|June 7, 2013
Differential impact of inflammation on six laboratory assays measuring residual arachidonic acid-inducible platelet reactivity during dual antiplatelet therapyThomas Gremmel, Thomas Perkmann, Daniela Seidinger, et al.
Pageof 14

Showing results (61-70 of 133) with videos related to

Sort By:
Pageof 14
Angiology|February 28, 2018
Low Levels of High-Density Lipoprotein Cholesterol Are Linked to Impaired Clopidogrel-Mediated Platelet InhibitionPatricia P Wadowski, Silvia Lee, Christoph W Kopp, et al.
International Journal of Cardiology|October 9, 2012
Residual platelet activation through protease-activated receptors (PAR)-1 and -4 in patients on P2Y12 inhibitorsRoza Badr Eslam, Irene M Lang, Renate Koppensteiner, et al.
Journal of Clinical Medicine|June 7, 2020
Platelet-to-lymphocyte and Neutrophil-to-lymphocyte Ratios Predict Target Vessel Restenosis after Infrainguinal Angioplasty with Stent ImplantationSilvia Lee, Timothy Hoberstorfer, Patricia P Wadowski, et al.
Frontiers in Immunology|March 11, 2021
Glycocalyx as Possible Limiting Factor in COVID-19Patricia P Wadowski, Bernd Jilma, Christoph W Kopp, et al.
Thrombosis Research|March 29, 2017
Plasminogen activator inhibitor-1 4G/5G genotype and residual venous occlusion following acute unprovoked deep vein thrombosis of the lower limb: A prospective cohort studyGeorgiana-Aura Giurgea, Sophie Brunner-Ziegler, Bernd Jilma, et al.
European Journal of Clinical Investigation|October 14, 2016
β-blockers are associated with decreased leucocyte-platelet aggregate formation and lower residual platelet reactivity to adenosine diphosphate after angioplasty and stentingSilvia Lee, Markus Durstberger, Beate Eichelberger, et al.
Seminars in Thrombosis and Hemostasis|June 18, 2024
Platelet Pathophysiology: Unexpected New Research DirectionsAlan D Michelson, Andrew L Frelinger Iii, Robin L Haynes, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 5, 2013
Chronic kidney disease is associated with increased platelet activation and poor response to antiplatelet therapyThomas Gremmel, Markus Müller, Sabine Steiner, et al.
Cardiovascular Drugs and Therapy|December 18, 2020
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity?Maximilian Tscharre, Patricia P Wadowski, Constantin Weikert, et al.
Journal of Atherosclerosis and Thrombosis|June 7, 2013
Differential impact of inflammation on six laboratory assays measuring residual arachidonic acid-inducible platelet reactivity during dual antiplatelet therapyThomas Gremmel, Thomas Perkmann, Daniela Seidinger, et al.
Pageof 14